Antiviral activity of postbiotics from Bifidobacterium animalis subsp. lactis BB-12 and Lacticaseibacillus rhamnosus GG against SARS-CoV-2: In-vitro and food model evaluation
Enzyme and Microbial Technology · 2026-08 · 199 · 110899
DOI: 10.1016/j.enzmictec.2026.110899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2026-08. Verfasst von Roya Abedi Soleimani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic addr…. Hauptthemen laut MEDLINE: SARS-CoV-2, Probiotics, Antiviral Agents, Lacticaseibacillus rhamnosus. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented ongoing global health, economic, and societal challenges. In addition to respiratory complications, increasing evidence suggests that disruptions to the gut microbiota may influence disease susceptibility and severity, highlighting the importance of microbiome-based interventions in supporting host immunity. While probiotics have been widely explored for their immunomodulatory and antiviral effects, limitations regarding their stability and safety under certain conditions remain a concern. Postbiotics, defined as non-viable microbial metabolites, secreted factors, and ultrasonicated bacterial lysate components, represent a promising alternative due to their enhanced safety profile, stability, and emerging antiviral properties. This study investigated the antiviral efficacy of postbiotics derived from Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 against SARS-CoV-2 using Vero E6 cells cultures. Furthermore, a novel food-based antiviral model was developed by incorporating postbiotic supernatants and ultrasonicated bacterial lysate at a concentration of 1500 μg/mL into a yogurt matrix. The postbiotic-enriched yogurt achieved a 1.87-2.48 log₁₀ reduction in viral titer against the Wuhan strain of SARS-CoV-2 in vitro. These findings support the potential of postbiotics as functional food ingredients for viral risk reduction and contribute to the advancement of microbiome-derived antiviral strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Roya_abedi@ymail.com.
- Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Electronic address: Asgharabdoli7@gmail.com.
- Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: payammilani6@gmail.com.
- Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: naderxani1996m@gmail.com.
- Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Homayounia@tbzmed.ac.ir.
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Soleimani, R. A., Abdoli, A., Milani, P. G., Khani, N., & Homayouni-Rad, A. (2026). Antiviral activity of postbiotics from Bifidobacterium animalis subsp. lactis BB-12 and Lacticaseibacillus rhamnosus GG against SARS-CoV-2: In-vitro and food model evaluation. Enzyme and Microbial Technology, 199, 110899. https://doi.org/10.1016/j.enzmictec.2026.110899
Vancouver
Soleimani RA, Abdoli A, Milani PG, Khani N, Homayouni-Rad A. Antiviral activity of postbiotics from Bifidobacterium animalis subsp. lactis BB-12 and Lacticaseibacillus rhamnosus GG against SARS-CoV-2: In-vitro and food model evaluation. Enzyme and Microbial Technology. 2026;199:110899. doi:10.1016/j.enzmictec.2026.110899
BibTeX
@article{Soleimani2026,
author = {Soleimani, Roya Abedi and Abdoli, Asghar and Milani, Payam Gonbari and Khani, Nader and Homayouni-Rad, Aziz},
title = {Antiviral activity of postbiotics from Bifidobacterium animalis subsp. lactis BB-12 and Lacticaseibacillus rhamnosus GG against SARS-CoV-2: In-vitro and food model evaluation},
journal = {Enzyme and Microbial Technology},
year = {2026},
volume = {199},
pages = {110899},
doi = {10.1016/j.enzmictec.2026.110899}
}
EUVIMED